Maat Pharma SA MAAT.PA
€2.76 €0.04 (1.43%) 1D
Last Updated: Jun 23, 12:00 AM·XPAR
Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
MAAT.PA Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: February 05, 2026
Report Source: 2025 2nd Quarter Report
Maat Pharma SA. Stock Analysis MAAT.PA
France Health Care Micro Cap Report: Maat Pharma SA operates as a clinical-stage microbiome therapeutics company. The company employs 55 full-time employees The company went IPO on 2021-11-08. The firm specializes in the microbiome therapy that is aimed to treatment of Gut Microbiota alteration (Dysbiosis) using patient-specific biotherapeutics in patients with serious medical conditions. Its MaaT Microbiome Restoration Therapy (MMRB) discovery and analysis platform supports the evaluation of drug candidates, the determination of new disease targets and the identification of biomarkers for microbiome-related conditions.
Read More Maat Pharma SA (MAAT.PA) Chart
Key Statistics of Maat Pharma SA (MAAT.PA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
€2.80Volume
18.48KP/E Ratio (TTM)
-52 Week Range
Market Cap
126.87MAvg. Volume
64.78KDividend Yield
-Financial Metrics & Statements of Maat Pharma SA (MAAT.PA)
FAQ's for Maat Pharma SA (MAAT.PA)
- According to Musaffa’s Shariah screening methodology, Maat Pharma SA (MAAT.PA) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Maat Pharma SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in Maat Pharma SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Maat Pharma SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Maat Pharma SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Maat Pharma SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.